Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
| Short Descr | ONC OVAR SPHRD CELL PARP | Medium Descr | ONC OVAR SPHRD CLL CUL PARP INHIBITOR TUM RSPSE | Long Descr | Oncology (ovarian), spheroid cell culture, poly (ADP-ribose) polymerase (PARP) inhibitors (niraparib, olaparib, rucaparib, velparib), tumor response prediction for each drug | CLIA Waived (QW) | No | APC Status Indicator | Service Paid under Fee Schedule or Payment System other than OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-01-01 | Deleted | First appearance of deletion in codebook. |
| 2023-03-31 | Deleted | Code deleted |
| 2023-01-01 | Added | First appearance in codebook. |
| 2022-07-01 | Added | Code added. |
Get instant expert-level medical coding assistance.